STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[144] CeriBell, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144
Rhea-AI Filing Summary

Form 144 filing for CeriBell, Inc. (symbol: CBLL) discloses that an affiliate, Xingjuan Chao, plans to sell up to 25,000 common shares through Fidelity Brokerage Services. The proposed sale, valued at $470,000, represents roughly 0.07 % of the 36.14 million shares outstanding and is expected to occur on or about 07 July 2025 on the NASDAQ exchange.

The shares stem from an employee option granted on 07 July 2021 and exercised for cash on the same date as the planned sale. During the previous three months, the same seller executed six separate transactions totaling 75,000 shares and generating ≈ $1.23 million in gross proceeds.

No additional financial statements, earnings figures, or corporate actions are included in this filing. The document is limited to the proposed share sale details required under SEC Rule 144.

Positive
  • Sale size is immaterial relative to 36.14 million shares outstanding (≈ 0.07 %), limiting potential market impact.
Negative
  • Continued insider selling: 75 k shares already sold in the last three months, with another 25 k planned, may be perceived negatively by some investors.

Insights

TL;DR – Routine insider sale; limited impact due to small float percentage.

This Form 144 shows an insider planning to sell 25 k shares (<0.1 % of outstanding) after selling 75 k in the prior quarter. The filing supplies no operational or financial updates and merely satisfies Rule 144 notice requirements. Insider sales can signal personal liquidity events rather than corporate weakness. Given the minuscule portion of the float, the transaction should not materially move CBLL’s valuation absent other news.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does CeriBell’s latest Form 144 disclose?

The filing notifies the SEC of a planned sale of 25,000 common shares by insider Xingjuan Chao.

How many CeriBell (CBLL) shares are being sold?

25,000 shares, valued at approximately $470,000 based on the filing.

When is the proposed sale date?

Around 07 July 2025, according to the notice.

How significant is the sale relative to shares outstanding?

It equals roughly 0.07 % of the 36.14 million shares outstanding.

Has the insider recently sold more CBLL shares?

Yes. Six transactions over the past three months totaled 75,000 shares and about $1.23 million in proceeds.
CeriBell, Inc.

NASDAQ:CBLL

CBLL Rankings

CBLL Latest News

CBLL Latest SEC Filings

CBLL Stock Data

478.53M
29.22M
10.43%
84.44%
3.61%
Medical Devices
Electromedical & Electrotherapeutic Apparatus
Link
United States
SUNNYVALE